Cao Wu

Star

Aconitum kusnezoffii Rchb.

Not yet clinically reviewed

Family: Ranunculaceae Genus: Aconitum Species: kusnezoffii Pinyin: Cao Wu
Raw Wild Aconite Root草乌

Traditionally used for

  • Pain & joints

Cautions & contraindications

  • Pregnancy
  • Heart conditions
  • Toxic — professional use only
Moderate evidence · 18 studies

☯ TCM Properties

Category: wind-damp dispelling
Temperature: hot
Taste: pungent, bitter
Meridians: liver, spleen, kidney, heart
Functions:

Disperses Cold, scours out Wind, overcomes Dampness and stops pain; Reduces swellings and treats abscesses and lesions

Traditional Chinese Uses

Cao Wu (草乌) is the raw, unprocessed root of Aconitum kusnezoffii — Aconiti Kusnezoffii Radix in the Chinese Pharmacopoeia 2020, a monograph separate from the processed drug Zhi Cao Wu (Aconiti Kusnezoffii Radix Cocta). Raw Cao Wu is not administered internally in any amount. Wild aconite is generally held to be more toxic than the cultivated Sichuan species; its diester diterpenoid alkaloid content makes the raw root lethal at a few milligrams of alkaloid, and processing is what creates the therapeutic margin.

The profile traditionally attached to the name “Cao Wu” — dispersing Cold, scouring out Wind, overcoming Dampness and stopping pain in severe cold-damp bi with fixed intense joint and muscle pain — is the profile of the processed drug. See Zhi Cao Wu for dosing and clinical use.

Contraindicated in pregnancy. Incompatible with Ban Xia, Gua Lou, Bei Mu, Bai Ji and Bai Lian (the eighteen incompatibilities, 十八反). Practitioner-prescribed only.

Western Herbalism Properties

Actions:
analgesicanti-inflammatory

Click a node for details · double-click to expand it · Ctrl/⌘ + scroll or two fingers to zoom and pan.

Loading graph…

Botanical Description

Aconitum kusnezoffii Reichb. (Ranunculaceae), Kusnezoff monkshood, is the principal source of Cao Wu, "wild aconite," a perennial herb 70-150 cm tall native to northeastern China, Mongolia, Korea, and the Russian Far East in forest margins and meadows. The plant develops paired tuberous roots, one persistent and one regenerating; the dried lateral or main tuber is the medicinal portion. Stems are erect, glabrous, and sparsely branched above. Leaves are alternate, palmately deeply 3-5 parted into narrow, sharply incised lobes, dark green and glossy above. The striking dark purple to violet-blue flowers are borne in terminal racemes 10-30 cm long in late summer; each flower has the characteristic helmet-shaped upper sepal 1.5-2.5 cm long enclosing two hooked nectary petals and numerous stamens, with a follicle fruit ripening to release flat-winged seeds. The root contains highly toxic diterpenoid alkaloids (aconitine, mesaconitine, hypaconitine). In TCM, processed Cao Wu dispels wind-damp, warms the channels, and powerfully alleviates pain; raw root is strictly prohibited internally.

Active Constituents

Aconitine

C19-diester diterpenoid alkaloid (aconitine-type)

Concentration: Principal diester alkaloid of the unprocessed root; content varies with provenance, harvest season and plant part, and is the quantity the pharmacopoeial assay of Aconiti Kusnezoffii Radix is built around

Binds site 2 of the voltage-gated sodium channel and holds it open, abolishing inactivation and producing a persistent inward sodium current in cardiac, neuronal and skeletal muscle membranes; the result is repetitive firing, bidirectional and polymorphic ventricular tachycardia, and paraesthesia. The estimated lethal oral dose in an adult is on the order of a few milligrams of the pure alkaloid, which is among the narrowest therapeutic margins of any drug still in clinical use.

Mesaconitine

C19-diester diterpenoid alkaloid (aconitine-type)

Concentration: One of the three diester alkaloids quantified together with aconitine and hypaconitine in pharmacopoeial assays of the root

A sodium-channel opener of comparable potency to aconitine and, in several analyses of Aconitum kusnezoffii root, the more abundant of the two. It is a major contributor to the cardiotoxicity of the raw drug and is absorbed through intact skin from liniments and plasters as well as from decoctions.

Hypaconitine

C19-diester diterpenoid alkaloid (aconitine-type)

Concentration: The third of the three regulated diester alkaloids; generally the least abundant of the trio in Aconiti Kusnezoffii Radix

Shares the sodium-channel-opening mechanism of aconitine and mesaconitine and is routinely detected in the blood and urine of aconite poisoning patients, where it serves as an analytical marker of aconite ingestion.

Benzoylaconine

C19-monoester diterpenoid alkaloid

The C8 hydrolysis product of aconitine, formed when the acetyl ester is lost during heating or prolonged decoction. Comparative rat work reports it as very much less acutely toxic than aconitine while retaining some pharmacological activity, and the conversion of diester to monoester alkaloid is the chemical event that processing is meant to achieve.

Benzoylmesaconine

C19-monoester diterpenoid alkaloid

The monoester hydrolysis product of mesaconitine. Its rise, alongside a fall in the parent diester, is the standard analytical signature used to show that a batch of aconite root has actually been processed or decocted long enough.

Aconine

Amine alcohol (fully hydrolysed, non-esterified) diterpenoid alkaloid

The end point of the hydrolysis sequence, formed when the benzoyl ester is also lost under prolonged heating. Rat studies place its acute toxicity orders of magnitude below that of aconitine, so a preparation dominated by amine alcohol alkaloids is far safer than one still carrying intact diesters.

Diterpenoid alkaloid minor constituents of the root

C19- and C20-diterpenoid alkaloids

Systematic profiling of Aconitum kusnezoffii root has identified a large family of additional diterpenoid alkaloids beyond the three regulated diesters, so the pharmacopoeial three-alkaloid assay measures the dominant hazard rather than the whole alkaloid burden of the drug.

Water-soluble polysaccharides

Polysaccharide

Non-alkaloidal polysaccharide fractions have been isolated from Radix Aconiti Kusnezoffii and reported to have antitumour and immunostimulating activity in preclinical assay. They are not the reason the drug is used clinically and contribute nothing to its toxicity.

⚠ Drug Interactions

Raw Cao Wu (Radix Aconiti Kusnezoffii) and processed Zhi Cao Wu (Radix Aconiti Kusnezoffii Preparata) confused with one another

Major Evidence: Established

This record carries the Latin name Radix Aconiti Kusnezoffii Preparata, which names the processed drug, while the slug, the pinyin name Cao Wu and the parallel zhi-cao-wu record all identify this entry as the raw root. The two are pharmacologically different drugs. Raw Cao Wu carries its diester alkaloids intact; processing by prolonged steaming or boiling hydrolyses the C8 acetyl ester to the monoester alkaloids and, with further heating, the C14 benzoyl ester to the amine alcohols, a stepwise loss of toxicity of roughly two to three orders of magnitude that has been demonstrated directly by comparing unprocessed with processed aconite roots. A record in which the raw and the processed drug are indistinguishable invites a dispenser to supply raw root against a prescription written for the processed one, at doses set for the processed drug. Because the fatal dose is a few milligrams of alkaloid, that single substitution is lethal.

Clinical note: Treat the Latin name on this record as unreliable and confirm from the pinyin, the slug and the supplier's certificate of analysis which drug is actually in hand. Never dispense against the Latin name alone. Raw Cao Wu is a restricted, prescription-only toxic drug in China and is not interchangeable with Zhi Cao Wu at any dose.

Short or interrupted decoction (decoction time as a dosing variable)

Major Evidence: Established

Decoction is not merely extraction; it is the last stage of detoxification. Mass-spectrometric studies of the aconite decoction process show diester alkaloids undergoing ester exchange and hydrolysis in the boiling pot, with diester content falling and monoester and amine alcohol content rising as boiling continues. A dose that is safe after the traditional prolonged pre-decoction of aconite is not safe if the herb is added late, boiled briefly, taken as a powder, infused rather than boiled, or extracted into alcohol. Duration of boiling is therefore a dosing variable of the same order of importance as the weight on the scale.

Clinical note: Specify pre-decoction of aconite for the traditional extended period before the other herbs are added, and state it explicitly on the prescription. Do not dispense raw or processed Cao Wu in powder, pill, granule or tincture form for self-preparation, and warn patients that reducing the boiling time to save effort can be fatal.

Alcohol and medicinal wines (yao jiu, herbal liquor preparations)

Major Evidence: Established

Aconite alkaloids are considerably more soluble in ethanol than in water, and steeping in spirit performs no hydrolysis, so a medicinal wine concentrates intact diester alkaloids rather than degrading them. Reviews of the causes of herb-induced aconite poisoning in Asia and of contributory factors in fatal cases repeatedly identify home-made or commercially prepared aconite-containing liquors, and consumption of a larger-than-intended volume, as a recurrent lethal pattern.

Clinical note: Do not prescribe or condone aconite-containing alcoholic preparations. Ask specifically about herbal wines and home-steeped liquors when taking a history from any patient presenting with paraesthesia, vomiting and arrhythmia.

External application (plasters, liniments, medicated baths and compresses)

Major Evidence: Established

Aconitine and mesaconitine are absorbed through skin. Percutaneous absorption of both alkaloids has been measured directly from extracts of Radix Aconitum kusnezoffii, and systemic aconite poisoning following percutaneous absorption of Aconitum alkaloids is documented in the forensic literature. Broken skin, occlusive dressings, large treated areas, heat and prolonged contact all increase the absorbed dose, and the patient receives no warning taste or gastrointestinal signal.

Clinical note: Limit area, contact time and dose for any external Cao Wu preparation; never apply to broken or inflamed skin or under occlusion; and instruct patients to wash off and seek emergency care at the first perioral or fingertip tingling.

Digoxin and other cardiac glycosides

Major Evidence: Probable

Aconite alkaloids produce bidirectional ventricular tachycardia through persistent sodium-channel opening and consequent calcium overload; digitalis toxicity produces the same rhythm through sodium-potassium ATPase inhibition and calcium overload. The two mechanisms converge on the same arrhythmia, and bidirectional ventricular tachycardia is one of the very few rhythms in which either poison should be suspected. Case reports of herbal aconite poisoning presenting with bidirectional tachycardia establish the arrhythmogenic effect in humans.

Clinical note: Do not use aconite-containing prescriptions in any patient taking digoxin. If a patient on digoxin presents with bidirectional ventricular tachycardia, ask about Chinese herbal medicine as well as checking a digoxin level.

Antiarrhythmic drugs, beta-blockers and non-dihydropyridine calcium channel blockers

Major Evidence: Probable

Aconite poisoning presents with hypotension and bradycardia as well as with tachyarrhythmia, and both patterns are described in the clinical toxicology literature. Drugs that independently depress sinus node function, atrioventricular conduction or myocardial contractility add to that effect, and they also complicate recognition, because the bradycardia may be attributed to the prescribed drug rather than to the herb.

Clinical note: Avoid aconite in patients on rate-limiting cardiac drugs. Where aconite is unavoidable, the patient needs baseline and follow-up electrocardiography and explicit instructions to stop the herb and attend an emergency department for tingling, numbness, palpitation or syncope.

Herbs and foods contaminated with aconite root

Major Evidence: Established

Aconite poisoning is not confined to overdose or mislabelling. Contamination of other herbs by aconite root during collection, drying, storage, cutting or grinding is a documented cause of Aconitum alkaloid poisoning, and poisoning has also followed the culinary use of aconite roots. Retrospective Hong Kong series covering 1989 to 2010 and 2008 to 2020 record cases arising in the course of ordinary practice, including from correctly labelled material, with the alkaloids confirmed analytically in patient samples.

Clinical note: Buy from suppliers who segregate aconite processing from other herbs and who can produce alkaloid assays. Consider aconite in any acute poisoning with perioral paraesthesia and arrhythmia after a Chinese herbal decoction even when no aconite appears on the prescription, and send blood and urine for aconite alkaloid analysis.

Glycyrrhiza uralensis (Gan Cao, licorice root)

Moderate Evidence: Probable

Co-decoction of processed Radix Aconiti Kusnezoffii with Glycyrrhiza uralensis measurably changes the pharmacokinetics of licorice constituents in rats, and the reciprocal reduction of aconite toxicity by licorice is the reason the pair is classical. The interaction is real but it is a mitigation of degree, not a licence to raise the aconite dose or to shorten the decoction.

Clinical note: Retain licorice in aconite prescriptions where the pattern permits, but do not treat it as a safety net: correct processing, correct dose and prolonged pre-decoction remain the controls that matter. Watch for licorice-related pseudoaldosteronism separately.

Astragalus mongholicus root (Huang Qi, Astragalus Radix)

Moderate Evidence: Possible

A rat study of Astragalus Radix and aconite alkaloids reports altered intestinal absorption of the alkaloids in the presence of the Astragalus decoction. Any co-prescribed herb that raises the absorbed fraction of a drug with a therapeutic index this narrow shifts a safe dose towards a toxic one, even though the finding is preclinical and single-species.

Clinical note: Where Huang Qi and aconite appear in the same formula, keep the aconite at the low end of the range and do not escalate on the assumption that absorption is fixed.

Terminalia chebula fruit (He Zi), as in the Mongolian medicine pairing Zhicaowu-Hezi

Moderate Evidence: Possible

The processed Cao Wu and Terminalia chebula pairing used in Mongolian medicine has been reported to change relative messenger RNA expression levels of cytochrome P450 enzymes. Because the diester alkaloids are cleared by cytochrome P450-mediated metabolism, an induction or repression of those enzymes changes the exposure achieved by a fixed dose.

Clinical note: Treat this combination as pharmacokinetically active rather than inert; it is preclinical evidence only, so the practical response is dose conservatism rather than a specific adjustment.

Strong CYP3A4 inhibitors (for example ketoconazole, itraconazole, clarithromycin, ritonavir, grapefruit juice)

Major Evidence: Possible

Aconitine, mesaconitine and hypaconitine are cleared largely by oxidative and ester-hydrolytic metabolism, and their metabolites have been characterised in rat blood by sensitive chromatographic methods. Inhibiting that clearance raises plasma concentration of intact diester alkaloid. Direct human interaction studies have not been done, and given the lethality of the drug they are unlikely ever to be done, so this is mechanistic inference from established metabolic routes rather than a measured interaction.

Clinical note: Screen for azole antifungals, macrolides, protease inhibitors and regular grapefruit intake before prescribing any aconite-containing formula, and defer the aconite rather than adjusting its dose.

Pinellia ternata (Ban Xia), Trichosanthes kirilowii (Gua Lou), Fritillaria species (Bei Mu), Ampelopsis japonica (Bai Lian) and Bletilla striata (Bai Ji)

Theoretical Evidence: Theoretical

These five drugs are the group that the classical Eighteen Incompatibilities declare antagonistic to Wu Tou, the aconite roots, and the prohibition has governed prescribing for eight centuries. Modern pharmacological investigation of these specific pairs has not produced a consistent demonstration of increased toxicity, so the rule is recorded here as traditional doctrine rather than as an established pharmacological interaction.

Clinical note: Most practitioners and pharmacies observe the prohibition, and many jurisdictions and dispensing systems enforce it. Depart from it only with explicit justification, documented consent and a clear record of the reasoning.

Dosage

Form Amount Frequency Duration Population Notes
n/a Not dispensed — raw drug — — — Raw Cao Wu is not given internally. It is the starting material for Zhi Cao Wu (Aconiti Kusnezoffii Radix Cocta), dosed 1.5–3 g/day and pre-decocted 30–60 min (ChP 2020). Any gram-scale internal dose attributed to RAW Cao Wu is an error.

Preparation Methods

Not for internal use (raw drug)

Parts: raw root

Raw Cao Wu is pao zhi starting material, not a dispensable article. Internal use requires the processed root, Zhi Cao Wu (Aconiti Kusnezoffii Radix Cocta), at 1.5–3 g/day, pre-decocted 30–60 minutes.

Dui Yao — Herb Pairs

The classical two-herb combinations this herb appears in, each with an action neither herb has alone.

with Chuan Wu 川乌

Two related aconite roots that together strongly dispel wind-cold-damp, warm the channels and stop pain.

Chronic wind-cold-damp painful obstruction with numbness and pain. Both are highly toxic; processed forms only, long decoction, never with Ban Xia, Gua Lou, Bei Mu, Bai Lian or Bai Ji (eighteen incompatibilities); contraindicated in pregnancy.

Core pair of a classical formula — Xiao Huo Luo Dan, Tai Ping Hui Min He Ji Ju Fang

Evidence Tier

Moderate evidence · 18 studies

Recorded studies by study design, strongest design at the top. This is a study-design tier only, not a GRADE rating: it does not weigh risk of bias, consistency or precision.

Systematic review / meta-analysis

0

Randomized controlled trial

0

Other clinical trial

0

In vitro / animal

12

2 verified · 10 unverified

Show 12 studies

Verified: design read from PubMed for a DOI that resolves to the cited paper Unverified: taken from the study's recorded description

Clinical Studies

Incidence and Causes of Aconitum Alkaloid Poisoning in Hong Kong from 1989 to 2010

Chan Thomas Y. K. (2015) Phytotherapy Research retrospective case series Verified: Other / unclassified

A twenty-two year territory-wide review of Aconitum alkaloid poisoning setting out how often it occurred and what caused it. Recurrent causes include use of the raw rather than the processed root, overdose, inadequate decoction and contamination of other herbs, which places the hazard in ordinary dispensing practice rather than only in deliberate misuse.

A retrospective study on laboratory-confirmed acute Chinese medicine poisoning involving aconite in Hong Kong from 2008 to 2020

Lam Rex Pui Kin; Ting Shuk Ching; Chow Tsz Kit; Chua Ka Kit; Ku Ping Yui; Chan Chi Keung; Tse Man Li; Lau Eric Ho Yin; Zhao Jin; Rainer Timothy Hudson (2026) Hong Kong Journal of Emergency Medicine retrospective cohort

A thirteen-year review of acute Chinese medicine poisoning involving aconite in which the alkaloids were confirmed analytically rather than inferred from history. Laboratory confirmation matters because the clinical syndrome of perioral and limb paraesthesia with arrhythmia is otherwise easy to attribute elsewhere.

Contributory factors in herb-induced fatal aconite poisoning

Chan Thomas Y.K. (2012) Forensic Science International case series Verified: Other / unclassified

An analysis of the circumstances of fatal herb-induced aconite poisoning. The recurring contributory factors are excessive dose, use of unprocessed root, insufficient boiling and alcoholic extraction, all of which are decisions made before the patient ever takes the medicine.

Cardiotoxicity after accidental herb-induced aconite poisoning

Tai Y-T.; Lau C-P.; Young K.; But P.P-H. (1992) The Lancet case series

The clinical series that established the cardiotoxic syndrome of herbal aconite poisoning in the general medical literature, describing patients who developed ventricular arrhythmia after taking Chinese herbal decoctions containing aconite roots.

Bidirectional Tachycardia Induced by Herbal Aconite Poisoning

TAI YAU-TING; LAU CHU-PAK; BUT PAUL PUI-HAY; FONG PING-CHING; LI JOHN PO-SHAN (1992) Pacing and Clinical Electrophysiology case report Verified: Observational / case report

An electrophysiological description of bidirectional ventricular tachycardia caused by herbal aconite. The rhythm is characteristic enough that its appearance in a patient taking Chinese herbal medicine should prompt an immediate question about aconite.

Aconite poisoning following the percutaneous absorption of Aconitum alkaloids

Chan Thomas Y.K. (2012) Forensic Science International case series Verified: Other / unclassified

Documents systemic aconite poisoning arising from skin contact with Aconitum preparations rather than from ingestion, confirming that external application of aconite carries genuine systemic risk.

Percutaneous absorption of aconitine and mesaconitine in extracts of Radix Aconitum kusnezoffii

Liu Zhi-Min (2006) Journal of Chinese Integrative Medicine in vitro Verified: In vitro / animal

Measures transdermal penetration of aconitine and mesaconitine specifically from Aconitum kusnezoffii root extract, providing the quantitative basis for the skin-absorption hazard of Cao Wu plasters and liniments.

Exploring the ester-exchange reactions of diester-diterpenoid alkaloids in the aconite decoction process by electrospray ionization tandem mass spectrometry

Wang Yong; Shi Lei; Song Fengrui; Liu Zhiqiang; Liu Shuying (2003) Rapid Communications in Mass Spectrometry in vitro

Follows the diester-diterpenoid alkaloids through the boiling pot and shows the ester-exchange and hydrolysis chemistry that occurs during decoction. It is direct evidence that boiling changes the drug rather than merely extracting it.

Exploration of toxicity reducing mechanism of aconite alkaloids during decoction process using liquid chromatography-mass spectrometry

CHEN Ping; CHEN Yimin; CHEN Jia; TONG Hongbin; XU Zhiliang (2013) Chinese Journal of Chromatography in vitro

Tracks the fall in diester alkaloids and the corresponding rise in less toxic hydrolysis products as decoction proceeds, which is the analytical demonstration that decoction time is itself a safety variable.

LC Separation and Determination of Five Diester-Diterpenoid Alkaloids in the Unprocessed and Processed Aconite Roots

Liu Min; Zhang Hai; Zhao Liang; Zhao Baiyun; Dong Lingling; Zhu Zhenyu; Chai Yifeng (2008) Chromatographia in vitro

A side-by-side quantification of five diester-diterpenoid alkaloids in unprocessed against processed aconite root. It gives the numerical difference between the raw and the processed drug and is the reason the two cannot be treated as one entry in a reference database.

Biological activities and pharmacokinetics of aconitine, benzoylaconine, and aconine after oral administration in rats

Zhang Hai; Sun Sen; Zhang Wen; Xie Xiangqun; Zhu Zhenyu; Chai Yifeng; Zhang Guoqing (2015) Drug Testing and Analysis animal

Compares the diester alkaloid aconitine with its monoester and amine alcohol hydrolysis products in the same rat model, establishing the steep loss of toxicity along the diester to monoester to amine alkaloid sequence that processing is designed to drive.

Identification of Diterpenoid Alkaloids from the Roots of Aconitum kusnezoffii Reihcb.

Xu Ning; Zhao De-Feng; Liang Xin-Miao; Zhang Hua; Xiao Yuan-Sheng (2011) Molecules in vitro

A phytochemical survey of the diterpenoid alkaloids of Aconitum kusnezoffii root specifically, rather than of the better-studied Aconitum carmichaelii. It shows the alkaloid burden of this species extends well beyond the three diesters that regulatory assays measure.

Qualitative and quantitative analyses of aconite alkaloids in Aconiti kusnezoffii Radix, and NO inhibitory activity evaluation of the alkaloid extracts

LI Qin-Yu; WU Bo; GONG Xue; WANG Wen-Shuo; ZHU Jia-Xin; ZHANG Chun-Hong; ZHANG Na (2022) Food Science and Technology in vitro

Profiles and quantifies the aconite alkaloids of Aconiti kusnezoffii Radix and tests the alkaloid extracts for nitric oxide inhibition. It is species-specific analytical work on Cao Wu rather than extrapolation from Chuan Wu or Fu Zi.

Characterization of aconitine-type alkaloids in the flowers of Aconitum kusnezoffii by electrospray ionization tandem mass spectrometry

Wang Yong; Song Fengrui; Xu Qingxuan; Liu Zhiqiang; Liu Shuying (2003) Journal of Mass Spectrometry in vitro

Characterises aconitine-type alkaloids in the flowers of Aconitum kusnezoffii. The plant part is the flower and not the root that constitutes the drug, so the findings bear on the toxicity of the whole plant to foragers rather than on the composition of Cao Wu itself.

The influence of compatibility of processed radix Aconiti Kusnezoffii on the pharmacokinetic of four components in Glycyrrhiza uralensis Fisch

Zhou Bin; Zhang Jingze; Wu Shanshan; Zhuo Qu; Gao Wenyuan; Hao Juan; Man Shuli (2015) Journal of Ethnopharmacology animal Verified: In vitro / animal

Shows that co-administering processed Cao Wu changes the pharmacokinetics of four licorice constituents in rats, giving a measurable basis to the classical aconite and licorice pairing.

Traditional Chinese herbal medicine Astragalus Radix and its effects on intestinal absorption of aconite alkaloids in rats

Liang Xin-li; Ji Miao-miao; Chen Lai; Liao Ye; Kong Xiao-qiang; Xu Xi-qiang; Liao Zheng-gen; Wilson Danny W. (2021) Chinese Herbal Medicines animal

Reports that Astragalus Radix alters the intestinal absorption of aconite alkaloids in rats, a herb-herb pharmacokinetic effect on a drug whose safe dose depends on how much is absorbed.

Potential induction of the relative mRNA expression levels of CYP450 by Zhicaowu-Hezi (Aconiti kusnezoffii radix preparata and Terminalia chebula Retz.)

Zhu Junxuan; An Ming; Wang Weiting; Guo Jingjing; Chen Mengting; Fang Longlong; Wang Cen; Zhang Dong; Wu Guodong (2025) Frontiers in Pharmacology animal

Examines cytochrome P450 messenger RNA expression after the Mongolian medicine pairing of processed Cao Wu with Terminalia chebula, indicating the combination is metabolically active and could change exposure to the aconite alkaloids.

The Antitumor and Immunostimulating Activities of Water Soluble Polysaccharides from Radix Aconiti, Radix Aconiti Lateralis and Radix Aconiti Kusnezoffii

Gao Tingting; Bi Hongtao; Ma Shuai; Lu Jingmei (2010) Natural Product Communications in vitro

Isolates water-soluble polysaccharides from three aconite drugs including Radix Aconiti Kusnezoffii and reports antitumour and immunostimulating activity. The activity belongs to a non-alkaloidal fraction and has no bearing on the clinical use or the toxicity of the whole drug.

⚠ Safety & Contraindications

  • Pregnancy
  • Heart conditions
  • Toxic — professional use only

Contraindications

Contraindicated in pregnancy and in cardiac disease.

Safety Warnings

  • The severe grade applies to the raw root; only the processed form is used clinically.
  • Decoct first for at least 30 to 60 minutes.
  • Incompatible with Ban Xia, Gua Lou, Bei Mu, Bai Lian and Bai Ji.

⚠ Rule-Based Cautions

These entries come from the deterministic rule tables that gate Verscienta's formula tools — classical pair prohibitions, pregnancy and lactation contraindications, and dose ceilings.

Incompatibilities (十八反 / 十九畏)

  • 十八反: Wu Tou × Ban Xia — avoid combining with Ban Xia / Pinellia (pair accepted when both members are processed)
  • 十八反: Wu Tou × Gua Lou — avoid combining with Gua Lou / Trichosanthes / Tian Hua Fen
  • 十八反: Wu Tou × Bei Mu — avoid combining with Bei Mu / Fritillaria / Chuan Bei / Zhe Bei
  • 十八反: Wu Tou × Bai Lian — avoid combining with Bai Lian / Ampelopsis
  • 十八反: Wu Tou × Bai Ji — avoid combining with Bai Ji / Bletilla

Pregnancy

Avoid toxic aconite

Breastfeeding

Avoid toxic to infant

Dose Ceiling

≤15g — prepared aconite 3–15g and must be pre-decocted; higher risks toxicity

≤6g — raw/less-processed aconite extremely toxic; keep low and pre-decoct

⚠ Toxicity Information

Level: severe
Toxic compounds: Diester diterpene alkaloids — aconitine, mesaconitine, hypaconitine; generally present at higher concentration than in Chuan Wu.
Symptoms:

Numbness of the mouth and limbs, vomiting, cardiac arrhythmia, hypotension, respiratory paralysis. Fatal poisonings are documented.

Historical Texts

Shen Nong Ben Cao Jing (Divine Husbandman's Classic of the Materia Medica)

Han dynasty, compiled by about 200 CE
Places Wu Tou, the aconite roots, in the lowest of the three classes, the drugs reserved for treating disease rather than for nourishing life and explicitly recognised as poisonous and unsuitable for prolonged use. The toxicity of this drug has never at any point in its history been in doubt.

Lei Gong Pao Zhi Lun (Master Lei's Treatise on the Processing of Drugs)

Liu Song dynasty, about 500 CE
The founding text of pao zhi, the processing tradition, which prescribes soaking and heating procedures for aconite. The whole point of the processing described here is to make a lethal root into a usable drug, which is why raw and processed aconite must be recorded as two distinct entries.

Ru Men Shi Qin (Confucians' Duties to their Parents), Zhang Congzheng

Jin dynasty, 1228
Transmits the Eighteen Incompatibilities, the classical list of antagonistic pairs, in which the aconite roots are declared incompatible with Ban Xia, Gua Lou, Bei Mu, Bai Lian and Bai Ji. The prohibition still governs dispensing practice in many jurisdictions.

Ben Cao Gang Mu (Compendium of Materia Medica), Li Shizhen

Ming dynasty, 1596
Separates the aconite drugs, describes their processing, and records the doses and the poisonings. Li Shizhen treats Cao Wu, the wild aconite root, as harsher and less predictable than the cultivated Chuan Wu, a distinction that modern alkaloid analysis has broadly upheld.

References

  1. Chan Thomas Y.K.. Aconite poisoning . Clinical Toxicology (2009) [DOI]
  2. Chan Thomas YK. Causes and prevention of herb-induced aconite poisonings in Asia . Human & Experimental Toxicology (2011) [DOI]
  3. Chan Thomas. Aconitum Alkaloid Poisoning Related to the Culinary Uses of Aconite Roots . Toxins (2014) [DOI]
  4. Chan Thomas Y. K.. Aconitum Alkaloid Poisoning Because of Contamination of Herbs by Aconite Roots . Phytotherapy Research (2015) [DOI]
  5. Chan Thomas YK. Aconite poisoning presenting as hypotension and bradycardia . Human & Experimental Toxicology (2009) [DOI]
  6. Ye Ling; Gao Song; Feng Qian; Liu Wei. Development and validation of a highly sensitive UPLC-MS/MS method for simultaneous determination of aconitine, mesaconitine, hypaconitine, and five of their metabolites in rat blood and its application to a pharmacokinetics study of aconitine, mesaconitine, and hypaconitine . Xenobiotica (2011) [DOI]

This information is for educational purposes only and is not intended to replace professional medical advice. Always consult a qualified healthcare provider before using any herbal remedy, especially if you are pregnant, nursing, or taking medications.

📝 Notes

Public notes from the community and your own private notes on Cao Wu.

No notes yet.

Log in or register to add your own notes.

Back to Herb Database